HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Not yet recruiting · NCT07483749 · Registry updated 2026-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Not yet recruiting | Not stated | 2026-03-19 | NCT07483749 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Women and Children's Hospital of Ningbo University | Ningbo | China | 1 |
| Children's Hospital, Zhejiang University School of Medicine | Hangzhou | China | 3 |
| Hangzhou Children's Hospital | Hangzhou | China | 1 |